Literature DB >> 4352966

Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins.

R J Havel, J P Kane.   

Abstract

Lipoproteins of very low density that are unusually rich in cholesteryl esters accumulate in blood plasma in a characteristic primary form of human hyperlipoproteinemia. These lipoproteins, which are thought to be products of the initial catabolic step in the metabolism of normal triglyceride-rich lipoproteins, have beta rather than pre-beta mobility on electrophoresis, presumably because they have lost certain protein components from their surface. In this study, we have used polyacrylamide gel electrophoresis of apoprotein components that are soluble in tetramethylurea to show that the very low-density lipoprotein fraction of blood serum from seven patients with hyperlipoproteinemia contains unusually large amounts of an arginine-rich protein. Pre-beta migrating, very low-density lipoproteins separated from serum of post-absorptive patients and chylomicrons obtained after a fat-rich meal contain normal amounts of this arginine-rich protein, but beta-migrating, very low-density lipoproteins and chylomicron-like particles separated from serum of post-absorptive patients contain more than twice as much. These apparently partially degraded lipoproteins also contain more tetramethylurea-insoluble protein and smaller amounts of the other soluble protein components than their normal counterparts.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4352966      PMCID: PMC433655          DOI: 10.1073/pnas.70.7.2015

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  The alpha2 lipoproteins of human serum; correlation of ultracentrifugal and electrophoretic properties.

Authors:  H G KUNKEL; R TRAUTMAN
Journal:  J Clin Invest       Date:  1956-06       Impact factor: 14.808

2.  Early effects of fat ingestion on lipids and lipoproteins of serum in man.

Authors:  R J HAVEL
Journal:  J Clin Invest       Date:  1957-06       Impact factor: 14.808

3.  Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components.

Authors:  V G Shore; B Shore
Journal:  Biochemistry       Date:  1973-01-30       Impact factor: 3.162

4.  Amino acid analysis of stained bands from polyacrylamide gels.

Authors:  L L Houston
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

5.  Electrophoretic separation of plasma lipoproteins in agarose gel.

Authors:  R P Noble
Journal:  J Lipid Res       Date:  1968-11       Impact factor: 5.922

6.  Isolation and characterization of polypeptides of human serum lipoproteins.

Authors:  B Shore; V Shore
Journal:  Biochemistry       Date:  1969-11       Impact factor: 3.162

7.  Very low density lipoprotein subfractions in a subject with broad-beta disease (Type 3 hyperlipoproteinemia) and a subject with endogenous lipemia (Type IV). Chemical composition and electrophoretic mobility.

Authors:  W R Hazzard; F T Lindgren; E L Bierman
Journal:  Biochim Biophys Acta       Date:  1970-05-05

8.  Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans.

Authors:  T Sata; R J Havel; A L Jones
Journal:  J Lipid Res       Date:  1972-11       Impact factor: 5.922

9.  Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia).

Authors:  W R Hazzard; D Porte; E L Bierman
Journal:  J Clin Invest       Date:  1970-10       Impact factor: 14.808

10.  On thelipoprotein abnormality in type 3 hyperlipoproteinemia.

Authors:  S Quarfordt; R I Levy; D S Fredrickson
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

View more
  42 in total

1.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

2.  Lipoproteins in lecithin-cholesterol-acyltransferase(LCAT)-deficiency. II. Further studies on the abnormal high-density-lipoproteins.

Authors:  G Utermann; H J Menzel; K H Langer; P Dieker
Journal:  Humangenetik       Date:  1975

3.  Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia.

Authors:  J R Patsch; R L Jackson; A M Gotto
Journal:  Klin Wochenschr       Date:  1977-11-01

4.  Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.

Authors:  S H Gianturco; A M Gotto; R L Jackson; J R Patsch; H D Sybers; O D Taunton; D L Yeshurun; L C Smith
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

5.  Biologically active low density lipoprotein in human peripheral lymph.

Authors:  D Reichl; N B Myant; M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

6.  apoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Alexander Vezeridis; Ioannis Dafnis; Angeliki Chroni; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2014-04-28       Impact factor: 5.922

7.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

Authors:  E S Krul; M J Tikkanen; T G Cole; J M Davie; G Schonfeld
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

9.  Hyperlipoproteinaemia and atherosclerosis in rabbits fed low-level cholesterol and lecithin.

Authors:  C E Hunt; L A Duncan
Journal:  Br J Exp Pathol       Date:  1985-02

10.  LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's disease.

Authors:  Jose F Abisambra; Tina Fiorelli; Jaya Padmanabhan; Peter Neame; Inge Wefes; Huntington Potter
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.